Globus Medical GMED EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Globus Medical’s reported figures.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's EBITDA?
- Globus Medical (GMED) reported EBITDA of $220.24M in Q1 2026.
- How has Globus Medical's EBITDA changed year-over-year?
- Globus Medical's EBITDA increased by 35.4% year-over-year, from $162.66M to $220.24M.
- What is the long-term trend for Globus Medical's EBITDA?
- Over 4 years (2021 to 2025), Globus Medical's EBITDA has grown at a 33.0% compound annual growth rate (CAGR), from $241.82M to $756.66M.
- What does EBITDA mean?
- Operating cash profit before interest, taxes, and non-cash charges.
- How do you interpret EBITDA?
- Higher is better and widely used to value capital-intensive businesses, but it ignores the real cost of capex — pair it with free cash flow. (Defined as EBIT + D&A so EBITDA = EBIT + D&A holds exactly.)
- How does EBITDA compare across companies?
- Standard cross-company operating-profit proxy for non-financials; not meaningful for banks and insurers.